AGIOS PHARMACEUTICALS, INC. SERIES C-1 CONVERTIBLE PREFERRED STOCK AND SERIES C-2 CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT Dated as of November 16, 2011Series C-1 and C-2 Convertible Preferred Stock Purchase Agreement • August 6th, 2013 • Celgene European Investment Co LLC • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 6th, 2013 Company Industry JurisdictionThis Agreement (“Agreement”) dated as of November 16, 2011 is entered into by and among Agios Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the individuals and entities listed on Exhibit A hereto (the “Purchasers”).